Through techniques such as adoptive cell-transfer therapy, tumor and immune cell co-cultures, and humanized mice, PDX and organoid models are increasingly being utilized to study CRC tumor-immune interactions as well as identifying immunotherapy targets in the NF-κB signaling pathway [65,91,92,93,94]. This evidence concerns the gene NFKB1 and neoplasm.